Key result
Automated whole-volume measurement of pancreatic CT fat fraction at -20 HU showed a significant positive correlation with MRI proton-density fat fraction (ρ = 0.905, p < 0.001).
Why the study?
The feasibility of pancreatic steatosis quantification by automated whole-volume CT fat fraction measurement compared to MRI proton-density fat fraction techniques required assessment.
Does automated whole-volume measurement of CT fat fraction correlate with MRI PDFF for quantifying pancreatic steatosis?
Observational (n=59)
Does automated whole-volume measurement of CT fat fraction correlate with MRI PDFF for quantifying pancreatic steatosis?
Automated whole-volume measurement of CT fat fraction using a -20 HU threshold is a feasible and convenient technique for quantifying pancreatic steatosis that correlates well with MRI.
Answers are grounded in this paper and cite their sources.
May support CT fat fraction as convenient alternative to MRI for pancreatic steatosis; leaves open prospective validation before clinical adoption.
Objectives: This study aimed to assess the feasibility of pancreatic steatosis quantification by automated whole-volume measurement of the fat fraction of the pancreas on CT in comparison to MRI using proton-density fat fraction (PDFF) techniques. Methods: Fifty-nine patients who underwent both CT and MRI were analyzed. Automated whole-volume measurement of pancreatic fat on unenhanced CT was performed by a histogram analysis with local thresholding. Three sets of CT fat volume fraction (FVF) (%) values with thresholds of −30 Hounsfield unit (HU), −20 HU and −10 HU were compared to MR-FVF (%) values measured on a PDFF map. Results: The median −30 HU CT-FVF, −20 HU CT-FVF, −10 HU CT-FVF and MR-FVF values of the pancreas were 8.6% (interquartile range (IQR), 11.3), 10.5% (IQR, 13.2), 13.4% (IQR, 16.1) and 10.9% (IQR, 9.7), respectively. The −30 HU CT-FVF (%), −20 HU CT-FVF (%) and −10 HU CT-FVF (%) of the pancreas showed a significant positive correlation with the MR-FVF (%) of the pancreas (ρ = 0.898, p < 0.001, ρ = 0.905, p < 0.001, ρ = 0.909, p < 0.001, respectively). The −20 HU CT-FVF (%) displayed reasonable agreement with the MR-FVF (%) with a low absolute fixed bias (mean difference, 0.32%; limit of agreement from −10.1 to 10.7%). Conclusion: The automated whole-volume measurement of the CT fat fraction of the pancreas using the threshold CT attenuation value of −20 HU may be a feasible, non-invasive, and convenient technique for quantifying pancreatic steatosis. Advances in knowledge: CT-FVF value of the pancreas had a positive correlation with the MR-FVF value. The −20 HU CT-FVF may be a convenient technique for quantifying pancreatic steatosis.
No takes yet. Share an insight, caveat, or question.
Tanabe et al. (2023) conducted an observational in Pancreatic steatosis (n=59). Automated whole-volume measurement of CT fat fraction vs. MRI using proton-density fat fraction (PDFF) was evaluated on Correlation between CT fat volume fraction (FVF) and MR-FVF (ρ = 0.905, p=<0.001). Automated whole-volume measurement of pancreatic CT fat fraction at -20 HU showed a significant positive correlation with MRI proton-density fat fraction (ρ = 0.905, p < 0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: